Aug 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 2.09B | £ 1.00B | £ 1.73B | £ 1.55B | £ 1.49B |
Total Assets | £ 27.09B | £ 26.91B | £ 25.68B | £ 25.16B | £ 26.47B |
Total Debt | £ 7.27B | £ 7.38B | £ 7.30B | £ 6.84B | £ 6.94B |
Net Debt | £ 5.18B | £ 6.38B | £ 5.58B | £ 5.29B | £ 5.44B |
Total Liabilities | £ 19.16B | £ 18.49B | £ 18.60B | £ 18.56B | £ 19.28B |
Stockholders Equity | £ 7.93B | £ 8.42B | £ 7.08B | £ 6.60B | £ 7.19B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |